Treat-to-target in pediatric rheumatic diseases

S Rosina, AI Rebollo-Giménez, A Consolaro… - Current Rheumatology …, 2023 - Springer
Abstract Purpose of Review To summarize the current evidence on the adoption of the treat-
to-target (T2T) strategy in pediatric rheumatic diseases (PRD). Recent Findings The recent …

Childhood-Onset Systemic Lupus Erythematosus (cSLE): An International Perspective

A Aggarwal, TAP Fernandes, A Migowa… - Current Allergy and …, 2024 - Springer
Abstract Purpose of Review Childhood-onset systemic lupus erythematosus (cSLE) is a
severe and potentially life-threatening chronic autoimmune disease. cSLE is more …

Evaluation of belimumab in treatment of Chinese childhood-onset systemic lupus erythematosus: a prospective analysis from a multicentre study

L Wang, X Liang, Z Cao, D Wang, Y Luo, Y Feng… - …, 2024 - academic.oup.com
Objective The aim of this study is to identify whether low lupus disease activity status
(LLDAS) and clinical remission (CR) of belimumab plus standard of care (SoC) therapy are …

Active implementation of low disease activity state as a treatment endpoint in childhood-onset systemic lupus erythematosus in routine practice is both feasible and …

R Gotch, Y Ahmed, R Wilson, E Hawkins… - Clinical Rheumatology, 2024 - Springer
Introduction Treat-to-target (T2T) strategies aim to facilitate tight disease control to improve
outcomes. No previous studies evaluated prospectively the feasibility and impact of the T2T …

Contributors to organ damage in childhood lupus: corticosteroid use and disease activity

M Hanif, C Sarker, E Al-Abadi, K Armon, K Bailey… - …, 2024 - academic.oup.com
Objectives Awareness of paediatric-specific predictors of damage in childhood lupus is
needed to inform mitigation measures. The objective of this study was to ascertain how …

[HTML][HTML] Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force

EMD Smith, A Aggarwal, J Ainsworth, E Al-Abadi… - Clinical …, 2024 - Elsevier
Objective To derive childhood-onset SLE (cSLE) specific remission definitions for future treat-
to-target (T2T) trials, observational studies, and clinical practice. Methods The cSLE …

Long-term outcomes and predictive factors of achieving low disease activity status in childhood systemic lupus erythematosus: a Chinese bicentric retrospective …

XX Yu, J Deng, QX Chen, SY Qiu, CH Jiang… - Frontiers in …, 2024 - frontiersin.org
Background This study aims to explore the clinical value of low disease activity state (LDAS)
in the treat-to-target strategy of pediatric systemic lupus erythematosus (pSLE) and find the …

Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus

H Kisaoglu, S Sener, E Aslan, O Baba, S Sahin… - …, 2024 - academic.oup.com
Objectives The objectives of this study were to assess the association between serological
activity (SA) and clinical inactivity in SLE and to investigate whether SA predicts flare after …

Updates in the care and management of children and adolescents with systemic lupus erythematosus

CA Silva, NE Aikawa, E Bonfa - Current Opinion in Rheumatology, 2024 - journals.lww.com
Current studies highlighted the various facets of cSLE, epidemiology, clinical, laboratory,
classification criteria, adolescent issues, prognosis, surveillance, T2T approach and drug …

[HTML][HTML] First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort

SC Bergkamp, T Kanagasabapathy, MP Gruppen… - Clinical …, 2024 - Elsevier
Objectives To validate the childhood lupus low disease activity state (cLLDAS) definition in
cSLE by describing differences in time to reach first adult LLDAS (aLLDAS) versus cLLDAS …